These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 1338654

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wied GL, Dowlatshahi K.
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [Abstract] [Full Text] [Related]

  • 3. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R, Werner J.
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract] [Full Text] [Related]

  • 4. Definition of precancerous and high-risk mammary lesions.
    Bégin LR.
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM, Lydersen S, Hagmar BM.
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH.
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Morphological diagnosis and prognosis in early ductal breast cancer].
    Frank GA, Volchenko NN.
    Vopr Onkol; 1992 Jan; 38(3):299-310. PubMed ID: 1338666
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M, Bachmann FF.
    Med Welt; 1982 Jul 16; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract] [Full Text] [Related]

  • 15. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG.
    Eur J Cancer Clin Oncol; 1983 Dec 16; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mammary duct proliferation in the elderly. A histopathologic study.
    Kramer WM, Rush BF.
    Cancer; 1973 Jan 16; 31(1):130-7. PubMed ID: 4345607
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L.
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan 16; 35(1):4-7. PubMed ID: 16608640
    [No Abstract] [Full Text] [Related]

  • 20. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S, Wei B, Zhang H, Qing M, Bu H.
    Oncol Rep; 2008 Jun 16; 19(6):1469-75. PubMed ID: 18497952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.